ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 07 Nov 2022
Last Applicant/ Owned by
545 Fifth Avenue, Suite 1400
New York
NY
10017
Serial Number
90430285 filed on 30th Dec 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
EMZIVIQ
Pharmaceutical preparations for treatment of diabetes complications; Pharmaceutical preparations for treatment of heart diseases or disorders, eye diseases or disorders, nervous system diseases or disorders, kidney diseases or disorders, cardiomyopathy, neuropathy, retinopathy, and nephropathy; Pharmaceutical preparations for inhibiting aldose reductase
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for treatment of diabetes complications; Pharmaceutical preparations for treatment of heart diseases or disorders, eye diseases or disorders, nervous system diseases or disorders, kidney diseases or disorders, cardiomyopathy, neuropathy, retinopathy, and nephropathy; Pharmaceutical preparations for inhibiting aldose reductase
Mark Details
Serial Number
No 90430285
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 761350.00238
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th Nov 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 07th Nov 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| 12th Sep 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 12th Sep 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 12th Sep 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 24th Mar 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 22nd Mar 2022 | SOU EXTENSION 1 GRANTED |
| 22nd Mar 2022 | SOU EXTENSION 1 FILED |
| 22nd Mar 2022 | TEAS EXTENSION RECEIVED |
| 05th Oct 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |